You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Type I interferonopathies in pediatric rheumatology
|
|---|---|
| Published in |
Pediatric Rheumatology, June 2016
|
| DOI | 10.1186/s12969-016-0094-4 |
| Pubmed ID | |
| Authors |
Stefano Volpi, Paolo Picco, Roberta Caorsi, Fabio Candotti, Marco Gattorno |
| Abstract |
Defective regulation of type I interferon response is associated with severe inflammatory phenotypes and autoimmunity. Type I interferonopathies are a clinically heterogenic group of Mendelian diseases with a constitutive activation of this pathway that might present as atypical, severe, early onset rheumatic diseases. Skin vasculopathy with chilblains and livedo reticularis, interstitial lung disease, and panniculitis are common. Recent studies have implicated abnormal responses to nucleic acid stimuli or defective regulation of downstream effector molecules in disease pathogenesis. As observed for IL1-β and autoinflammatory diseases, knowledge of the defects responsible for type I interferonopathies will likely promote the development of targeted therapy. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Singapore | 1 | 33% |
| Australia | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 159 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Israel | 1 | <1% |
| Spain | 1 | <1% |
| France | 1 | <1% |
| Unknown | 156 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 20 | 13% |
| Student > Ph. D. Student | 19 | 12% |
| Other | 17 | 11% |
| Student > Doctoral Student | 15 | 9% |
| Student > Postgraduate | 13 | 8% |
| Other | 53 | 33% |
| Unknown | 22 | 14% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 57 | 36% |
| Immunology and Microbiology | 19 | 12% |
| Biochemistry, Genetics and Molecular Biology | 15 | 9% |
| Unspecified | 11 | 7% |
| Agricultural and Biological Sciences | 9 | 6% |
| Other | 18 | 11% |
| Unknown | 30 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2020.
All research outputs
#13,238,608
of 22,876,619 outputs
Outputs from Pediatric Rheumatology
#346
of 697 outputs
Outputs of similar age
#171,915
of 339,397 outputs
Outputs of similar age from Pediatric Rheumatology
#7
of 10 outputs
Altmetric has tracked 22,876,619 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 697 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 339,397 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.